Koers Parnell Pharmaceuticals Holdings Ltd Nasdaq
Aandelen
AU0000XINEU9
Farmaceutische producten
Omzet 2020 | 30 mln. 20,08 mln. 18,47 mln. | Omzet 2021 | 34,17 mln. 22,86 mln. 21,03 mln. | Marktkapitalisatie | 4,08K 2,73K 2,51K |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -15 mln. -10,04 mln. -9,23 mln. | Nettowinst (verlies) 2021 | -1 mln. -669K -616K | EV/omzet 2020 | 2,18 x |
Nettoschuld 2020 | 56,16 mln. 37,58 mln. 34,57 mln. | Nettoschuld 2021 | 58,89 mln. 39,41 mln. 36,25 mln. | EV/omzet 2021 | 1,72 x |
K/w-verhouding 2020 |
-0,56
x | K/w-verhouding 2021 |
-
| Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01-02-10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,83% | 79,42 mld. | |
+28,00% | 3,8 mld. | |
-1,39% | 3,23 mld. | |
+21,28% | 1,75 mld. | |
-3,25% | 1,61 mld. | |
-18,63% | 1,36 mld. | |
-1,17% | 1,3 mld. | |
-6,77% | 1,22 mld. | |
+2,34% | 1,11 mld. |